With expertise in characterizing and modifying a drug substanceâ€™s physical, chemical and mechanical properties, our objective is to help you assess and choose the best solid form for progression into animal and human dosing trials.
AMRI's PAT approach is consistent with the FDA perspective that quality cannot be tested into products, but should be built in.
Cebiphar, French CRO member of TERANGA Group (100 employees), offers its preformulation studies for formulation development. Cebiphar’s sustained commitment to quality enables the performance of studies according to GMP, GLP and GCP quality standards.
Crystallics has capabilities to determine powder properties like bulk and tap density, flow properties, odor & color, electrostatics, compression properties, compaction properties, milling, grinding & granulation (chemical physical stability).
Country See All
New Zealand (1)
United Kingdom (1)
United States (2)
Companies See All